[1] Gunter MJ, Hoover DR, Yu H, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer[J].Cancer Epidemiol Biomarkers Prev, 2008,17(4):921-929.[2] Cust AE, Allen NE, Rinaldi S, et al.Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk;results from the European prospective investigation into cancer and nutrition[J]. Int J Cancer,2007,120(12):2656-2664.[3] Burzawa JK, Schmeler KM, Bevers MW, et al. Prospective evaluation of insulin resistance among endometrial cancer patients[J].Am J Obstet Gynecol, 2011,204(4):355.e1-7.[4] Mu N, Zhu Y, Wang Y, et al. Insulin resistance:a significant risk factor of endometrial cancer[J]. Gynecol Oncol, 2012, 125(3):751-757.[5] Vilavicencio A, Baeallao K, Gabler F, et al. Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia[J].Gynecol Oncol, 2007, 104(2):290-295.(2014-04-01收稿 2014-06-25修回) |